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Figure S1: 
1
H NMR spectrum of Compound 1  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2: 
13
C NMR spectrum of Compound 1 
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Figure S3: 
1
H NMR spectrum of EUA-1  
 
 
 
 
 
 
 
 
 
 
 
 
Figure S4: 
13
C NMR spectrum of EUA-1 
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Figure S5: 
1
H NMR spectrum of EUA-2 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S6: 
13
C NMR spectrum of EUA-2 
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Figure S7: 
1
H NMR spectrum of EUA-3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S8: 
13
C NMR spectrum of EUA-3 
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Figure S9: 
1
H NMR spectrum of Compound 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S10: 
13
C NMR spectrum of Compound 3 
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Figure S11: 
1
H NMR spectrum of EUA-4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S12: 
1
H NMR spectrum of EUA-5 
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Figure S13: Mass spectrum of Compound 1 
 
 
 
 
 
 
 
Figure S14: Mass spectrum of EUA-1 
 
 
 
 
 
 
 
 
Figure S15: Mass spectrum of EUA-2 
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Figure S16: Mass spectrum of EUA-3 
 
 
 
 
 
 
 
Figure S17: Mass spectrum of Compound 3 
 
 
 
 
 
 
 
Figure S18: Mass spectrum of EUA-4 
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Figure S19: Mass spectrum of EUA-5 
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Measurement and calculation of log P of the probe compounds with 
HPLC  
  
      Column：Cosmosil 5C18-MS-II Waters 4.6x150mm (Nacalai)  
   Wavelength: 254nm   
      Mobile phase: MeOH:0.04M Britton-Robinson buffer=5:2 (pH=7.5) 
   Britton-Robinson buffer: boric acid, acetic acid, phosphate (each 0.04M)  
  
       Standards:  
      t0 comfirmation solution: NaNO3 1g/ 50ml H2O (1) 
   Benzene 10mg/ 20ml acetonitrile (2) 
    Bromobenzene 10mg/ 20ml acetonitrile (3) 
    Hexachlorobenzen 10mg/ 20ml acetonitrile (4) 
    Biphenyl 10ml/ 50 ml acetonitrile (5) 
    (5) 5 ml/ 50 ml acetonitrile (5)' 
     
       samples:  
      (1) 1ml, (2)or(3)or(4) 2ml, acetonitrile 7ml (total 10 ml) 
   (1) 1ml, (5)' 1ml, acetonitrile 8ml (total 10 ml) 
    (1) 10 ul, 1mM EUA(1-5) 20 ul, acetonitrile 80 ul (total 100ul)  
   
       Inject quantity for HPLC: 25 ul 
     
       Table. 1 Retention Times and logPow of Standard Reagents 
   
         t0(min)      tR(min)     k'(tR-t0/t0)(min) 
  
logk'   logPow 
 Benzene 3.233 9.6 1.969 0.294 2.13 
 Bromobenzen 3.251 15.709 4.832 0.684 2.99 
 Biphenyl 3.231 33.834 9.472 0.976 3.76 
 Hexachlorobenzene 3.195 92.301 27.889 1.445 6.18 
 
 
(measured) 
   
(measured)              (calculated) (calc.) (known) 
 t0: retention time of NaNO3 
     tR: retention time of each compounds 
    k': capacity factor 
       (tR-t0)/t0 
      logk': natural logarithm of k' 
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       Fig.1 A regression line, logPow=3.501k'+0.790 (r=0.951) is obtained from data of table 1. 
       Some of LogP(HPLC) of EUA(1-5) are calculated from the measured and calculated data. 
       Table. 2 Retention Times and logP(HPLC) of BODIPY compounds 
   
 
t0(min) tR(min) k'(tR-t0/t0)(min) logk' logP(HPLC) 
EUA1 3.158 116.299 36.827 1.566 6.273 
 EUA2 3.867 112.753 28.158 1.449 5.863 
 EUA3 3.885 116.456 28.986 1.462 5.908 
 EUA4 3.938 111.807 27.392 1.438 5.824 
 EUA5 3.981 63.909 15.054 1.178 4.914 
 
 
(measured) (measured)             (calculated) (calc.) (calc.) 
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